Home United Therapeutics submits pre-market approval application for use...
 

Keywords :   


United Therapeutics submits pre-market approval application for use...

2014-12-26 10:50:53| Biotech - Topix.net

United Therapeutics Corporation announced today that Medtronic, Inc. has submitted a pre-market approval application to the U.S. Food and Drug Administration for the use of Medtronic's SynchroMedA II implantable drug infusion system for use with United Therapeutics' RemodulinA Injection delivered intravenously to patients with pulmonary arterial hypertension.

Tags: use united application approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11
25.1124cm
25.11! CDBest
25.1110
25.11 Y0385
25.11101138
25.11SideM Blu-ray
25.11 15th Anniversary CD & DVD BOX CLAMPAZAR
More »